AstraZeneca is reportedly considering moving its listing to the US. Here's why AZN's expected departure is alarming for the ...

In early corporate news, AstraZeneca receives EU approval for a bladder cancer therapy, and a subdued housing market leaves MJ Gleeson eyeing adjusted pretax profit at the lower end of current market ...

Sky's James Sillars writes that a government, struggling for authority and prioritising economic growth, can not afford to ...

(Reuters) -AstraZeneca is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as ...

AstraZeneca is considering moving its stock market listing from London, where it is the exchange's most valuable company, to ...

AstraZeneca Plc’s shares rose after a report that Chief Executive Officer Pascal Soriot wants to move the British drugmaker’s ...

In turn, while the overall impact from them is still yet to be seen, Mr Bailey says tightening rates further could be more ...

The company's exit from the U.K. market would spark a major index re-weighting, given AstraZeneca is the most valuable ...

The boss of Astrazeneca has reportedly voiced his desire to transfer the pharma giant's listing to the US, in what would be a ...

AstraZeneca chief executive Sir Pascal Soriot is reportedly considering the move due to growing frustration with the UK's ...

Cambridge UK Pharma giant AstraZeneca is proving a variation on the proverbial enigma as it ponders the most appreciative ...

London marked the slowest first half-year for IPO volume since 1997, a grim milestone punctuated by a report that AstraZeneca ...